[Current perspectives in the treatment of Parkinson disease].
Rodríguez
M
M
Palarea
M D
MD
Castro
R
R
Pérez
J
J
Arévalo
R
R
D001708:Biopterins / Q000031:analogs & derivatives / Q000378:metabolism; D001923:Brain Chemistry; D004298:Dopamine / Q000378:metabolism / Q000502:physiology; D018492:Dopamine Antagonists; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D018377:Neurotransmitter Agents / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D009435:Synaptic Transmission; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D018492:Dopamine Antagonists; D018377:Neurotransmitter Agents; D001708:Biopterins; D007980:Levodopa; D014446:Tyrosine 3-Monooxygenase; C003402:sapropterin; D004298:Dopamine
Perspectivas actuales en el tratamiento de la enfermedad de Parkinson.